Showing 1 - 10 of 1,790
Persistent link: https://www.econbiz.de/10011480752
This report assesses the magnitude, flows and drivers of illicit trade and the illegal economy including: narcotics, human trafficking, wildlife, sports betting, counterfeit medicines, alcohol and tobacco. The negative socio-economic impacts that these markets have in consumer countries are as...
Persistent link: https://www.econbiz.de/10012450586
, deterrence and roadside detection practices in member countries as well as preventative measures to combat drug use while driving …
Persistent link: https://www.econbiz.de/10012442820
Persistent link: https://www.econbiz.de/10000332845
All countries need vaccines but not all can produce them. Vaccine production is highly specialised, subject to comparative advantages, and concentrated in few countries, making trade a vital means to deploying vaccines broadly. Keeping markets open by reducing tariffs, streamlining trade-related...
Persistent link: https://www.econbiz.de/10012630122
The goods needed to vaccinate, protect and test during the COVID-19 pandemic are produced across many different countries. This brief tells the tale of three products ‒ vaccines, face masks and tests ‒ and highlights the role of trade in the fight against COVID-19. International markets and...
Persistent link: https://www.econbiz.de/10013202477
pharmaceutical products. Illicit markets for fake pharmaceuticals are attractive for counterfeiters, given the high profit margins … dangerous ingredients. Fake pharmaceuticals include antibiotics, lifestyle treatments, pain killers, anti-malarial drugs …
Persistent link: https://www.econbiz.de/10012451513
Secure medical supply chains are a cornerstone of resilient health systems. Medical supply chains are complex and internationalised, often involving many suppliers. The COVID-19 pandemic, which combined an unprecedented surge in demand with interruptions in supply and trade, exacerbated...
Persistent link: https://www.econbiz.de/10014568036
Persistent link: https://www.econbiz.de/10003410196
While the rapid development of vaccines against COVID‑19 is an extraordinary achievement, successfully vaccinating the global population presents many challenges, from production to distribution, deployment, and importantly, acceptance. Trust in the vaccines is vital, and is critically...
Persistent link: https://www.econbiz.de/10012630069